[Hiring] Director, Clinical & Value Evidence Liaison @MENARINI Group

Role Description

The Director, Clinical & Value Evidence Liaison is a field-facing role within Medical Affairs whose main objective is to be a trusted scientific partner to key external payer and other population health decision-maker (PHDM) experts by conducting timely, appropriate scientific exchanges to enhance the understanding of the scientific and clinical value of Menarini Stemline products. In addition, the Director will develop opportunities to partner with PHDMs in a collaborative research project capacity, meeting shared goals and objectives.

• External customers include Managed Care Organizations (MCOs), large physician groups, health systems, Group Purchasing Organizations (GPOs), Pharmacy Benefit Managements (PBMs), Governmental Agencies (VA/DoD System), Medicare, Integrated Delivery Networks (IDNs) and Oncology Clinical Pathway Developers in the assigned region/geography.
• Responsible for supporting and partnering with key internal business partners, primarily colleagues in Market Access.
• Contributes to business planning and internal business partner teams by providing strategic clinical and health outcomes input along with customer insights.
• Maintains a high level of key account management and builds external relationships with recognized experts in managed markets/healthcare systems.
• Supports pre- and post-launch activities and contributes to the company's efforts in communicating the high value of Menarini Stemline products to address unmet medical needs.
• Supports evidence generation through real-world evidence (RWE) initiatives.

Qualifications

• An advanced degree required (e.g., PharmD, DNP, PhD or MD); additional master’s degree in scientific research domain preferred (e.g., MS, MPH).
• Generally, 5-7 years of relevant experience, including 2+ years working as a Health Economics Outcomes Research (HEOR) Liaison in the biotech/pharmaceutical industry or a combination of experience working within a payer organization and as a HEOR Liaison; also includes 2+ years with direct HEOR/RWE project experience.
• Preferred knowledge or experience in the Oncology therapeutic area with experience in Breast Oncology preferred.
• Basic knowledge of payer quality and performance measures.
• Basic knowledge of health system incentives around pharmaceuticals.
• Familiar with health economics, outcomes research, disease management and practice/pathway guidelines and methodologies, comparative effectiveness research and trends.
• Must have a demonstrated ability to solve problems with innovative solutions along with strong organizational skills.
• Experience working with cross functional medical, market access, and commercial teams is required.
• Experience planning and executing HEOR and/or real-world evidence research projects.
• Excellent verbal and communication skills in multiple settings and the ability to manage multiple activities and projects and prioritize activities accordingly.
• Exceptional interpersonal and leadership skills to effectively communicate and build relationships with a broad spectrum of audiences at all organizational levels.
• Solid analytical and strategic capabilities and business acumen along with demonstrated work ethic, integrity, and professional conduct.
• Strong team players, take initiative, think strategically and creatively.
• Excellent project management skills.
• Strong Microsoft Office Suite (Excel, PowerPoint, Word) skills.
• Ability to travel, locally and regionally, up to 60% with overnight stays.

Requirements

• Develops and maintains expertise in the ever-evolving US healthcare landscape management and delivery.
• Understands dynamics of the health plan’s/PBM’s formularies and positioning of Menarini Stemline product(s).
• Possesses and develops ongoing expertise in health economics and outcomes research (HEOR) and real-world evidence (RWE).
• Provides clinical support and delivers data presentations regionally and nationally as needed for the PHDM audience.
• Represents and supports Menarini Stemline at relevant scientific or other key stakeholder meetings.
• Captures and documents key insights from PHDMs and analyzes insights into meaningful action items for the organization.
• Identifies, understands, and acts on unmet needs of prioritized PHDM stakeholders.
• Provides medical/scientific expertise in the development of content and programs for educating internal support functions and key internal stakeholders.
• Actively participates in select medical/outcomes research meetings, advisory boards, and internal meetings.
• Contributes to the development, management, and execution of the Medical Affairs Strategic Plan and all related pre- and post-launch activities.
• Develops and executes opportunities to partner with PHDMs in payer and institutional settings in data-centric projects.
• Collaborates with cross-functional partners in Account Management, Payer Marketing, Commercial Sales, and Clinical Development.
• Manages project work related to Medical Affairs activities and collaborates with cross-functional partners.
• Builds relationships with Medical Science Liaisons (MSLs) and other cross-functional partners in Market Access and Marketing.
• Consistently adheres to internal standard processes and comply with regulatory and compliance requirements.
• May travel up to 60%.
• Other duties as assigned.

Benefits

• Base Salary Range of $240,000-272,000.
• Generous compensation and benefits packages, including:
• Fidelity 401(k) (with company match).
• PPO and HDHP insurance plans.
• Company paid Basic Life & AD&D insurance.
• Pre-tax FSA/HSA programs.

Company Description

Menarini is a leading international biopharmaceutical company committed to advancing health through innovation, research, and quality. Founded in 1886 in Naples, Menarini has a strong commitment to oncology and invests in a pipeline of investigational compounds for the treatment of various tumors.

• Present in 70 countries with products sold in 140 locations worldwide.
• Employs around 18,000 employees and produces over 500 million packs of drugs annually.
• Strong focus on innovative therapeutic solutions and advanced liquid biopsy-based diagnostics.